Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America

BACKGROUND: Vancomycin is a common first-line option for MRSA infections. The heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) phenotype is associated with therapeutic failure. However, hVISA isolates are usually reported as vancomycin susceptible by routine susceptibility testing...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Castro, Betsy E, Berrio, Maritza, Vargas, Monica L, Carvajal, Lina P, Millan, Lina V, Rios, Rafael, Hernandez, Angie K, Rincon, Sandra, Cubides, Paola, Forero, Erika, Dinh, An, Seas, Carlos, Munita, Jose M, Arias, Cesar A, Reyes, Jinnethe, Diaz, Lorena
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7443737/
https://ncbi.nlm.nih.gov/pubmed/32562543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa221
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados